Seres Therapeutics, Inc. (MCRB) stock: key figures, P/E, revenue and dividend
Health Care · United States · ISIN US81750R2013
Seres Therapeutics, Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 789,000.00 USD |
| Operating income | -93.97 m USD |
| EBIT | 3.47 m USD |
| Net income | 5.70 m USD |
| Diluted EPS – continuing operations | 0.64 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Seres Therapeutics, Inc.
Seres Therapeutics, Inc., a clinical-stage company, focuses on developing biotherapeutics for serious diseases. The company develops SER-155, an investigational oral live biotherapeutic to decolonize GI pathogens, enhance GI epithelial barrier integrity, and regulate immune response to prevent bacterial bloodstream infections, as well as other pathogen-associated negative clinical outcomes in patients undergoing allogeneic hematopoietic stem cell transplantation. It also develops SER-603, a LBP candidate optimized to treat disruptions in the GI microbiome and to improve GI mucosal barrier integrity through the inhibition of inflammatory bacteria and associated metabolites; and SER-147, a live biotherapeutic composition to prevent bacterial bloodstream and spontaneous bacterial peritonitis infections in patients with metabolic disease, including chronic liver disease. The company was formerly known as Seres Health, Inc. and changed its name to Seres Therapeutics, Inc. in May 2015. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts.
More stocks
- Pacific Sports Exchange Inc. (PSPX)
- MINERALRITE Corp (RITE)
- SMITH MICRO SOFTWARE, INC. (SMSI)
- ACCESS Newswire Inc. (ACCS)
- NOBLE ROMANS INC (NROM)
- EON Resources Inc. (EONR)
- DarioHealth Corp. (DRIO)
- Norris Industries, Inc. (NRIS)
- Galenfeha, Inc. (NGHI)
- PACIFIC HEALTH CARE ORGANIZATION INC (PFHO)
- Hepion Pharmaceuticals, Inc. (HEPA)
- Bionano Genomics, Inc. (BNGO)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.